Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083198 · ClinicalTrials.gov registry record
Effects of IV Chloride Content on Outcomes
A clinical trial of SIRS and Balanced Fluids, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 1,558
- Enrollment target
- 1
- Study location
NCT02083198 is a study of SIRS and Balanced Fluids that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 1,558 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02083198, a study of SIRS and Balanced Fluids, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 1,558 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions are associated with adverse outcomes as measured by administrative data and by clinical parameters.
Conditions Studied
Study Locations (1)
Illinois
- Baxter Healthcare - Deerfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,558 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02083198
The ClinicalTrials.gov registry entry for NCT02083198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,558 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with SIRS appearing as the primary indexed condition, and to 0 interventions.
NCT02083198 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02083198 about?
NCT02083198 is a clinical study titled "Effects of IV Chloride Content on Outcomes". This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions ar...
What is the current status of trial NCT02083198?
This trial is currently completed. The enrollment target is 1,558 participants. The study started on 2013-09. Estimated completion is 2014-04-01.
What conditions does trial NCT02083198 study?
This clinical trial studies the following conditions: SIRS, Balanced Fluids, Plasmalyte.
Who is sponsoring clinical trial NCT02083198?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02083198 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SIRS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.